Updated survival analysis in patients with stage IIIB or IV non-small-cell lung cancer receiving BLP25 liposome vaccine (L-BLP25): phase IIB randomized, multicenter, open-label trial.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples